about
sameAs
A Nested Case-Control Study of Metabolically Defined Body Size Phenotypes and Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)Lifetime alcohol use and overall and cause-specific mortality in the European Prospective Investigation into Cancer and nutrition (EPIC) studyNutrient patterns and their food sources in an International Study Setting: report from the EPIC studyDietary flavonoid and lignan intake and breast cancer risk according to menopause and hormone receptor status in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study.Consumption of sweet beverages and type 2 diabetes incidence in European adults: results from EPIC-InterAct.Dietary intake of acrylamide and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition cohortDietary vitamin D intake and risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition: the EPIC-InterAct studyRisk of type 2 diabetes according to traditional and emerging anthropometric indices in Spain, a Mediterranean country with high prevalence of obesity: results from a large-scale prospective cohort studyMacronutrient composition of the diet and prospective weight change in participants of the EPIC-PANACEA studyDESCRIPTION OF INDEXES BASED ON THE ADHERENCE TO THE MEDITERRANEAN DIETARY PATTERN: A REVIEW.Lifestyle, dietary factors, and antibody levels to oral bacteria in cancer-free participants of a European cohort study.Prediagnostic circulating parathyroid hormone concentration and colorectal cancer in the European Prospective Investigation into Cancer and Nutrition cohortReproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort studyMediterranean diet and type 2 diabetes risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study: the InterAct projectFlavonoid and lignan intake in relation to bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study.Metabolomic profiles of hepatocellular carcinoma in a European prospective cohort.Reproductive factors and risk of mortality in the European Prospective Investigation into Cancer and Nutrition; a cohort study.Concentrations of IGF-I and IGFBP-3 and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition.Prediagnostic concentrations of plasma genistein and prostate cancer risk in 1,605 men with prostate cancer and 1,697 matched control participants in EPIC.A U-shaped relationship between plasma folate and pancreatic cancer risk in the European Prospective Investigation into Cancer and NutritionCellular immune activity biomarker neopterin is associated hyperlipidemia: results from a large population-based study.Flavonoid and lignan intake and pancreatic cancer risk in the European prospective investigation into cancer and nutrition cohort.Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study.The association between dietary flavonoid and lignan intakes and incident type 2 diabetes in European populations: the EPIC-InterAct study.The association of pattern of lifetime alcohol use and cause of death in the European prospective investigation into cancer and nutrition (EPIC) study.Dietary intakes of individual flavanols and flavonols are inversely associated with incident type 2 diabetes in European populations.Lung cancer in women: an overview with special focus on Spanish women.Risk of second cancers cancer after a first primary breast cancer: a systematic review and meta-analysis.Cumulative risk of second primary contralateral breast cancer in BRCA1/BRCA2 mutation carriers with a first breast cancer: A systematic review and meta-analysis.Risk of second primary cancer among women with breast cancer: a population-based study in Granada (Spain).Genomics in Primary and Secondary Prevention of Pancreatic Cancer.Compliance with dietary and nutrient recommendations in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Granada cohort at recruitment.Non-enzymatic antioxidant capacity (NEAC) estimated by two different dietary assessment methods and its relationship with NEAC plasma levels.Total dietary carbohydrate, sugar, starch and fibre intakes in the European Prospective Investigation into Cancer and Nutrition.Work, household, and leisure-time physical activity and risk of mortality in the EPIC-Spain cohort.A systems approach identifies time-dependent associations of multimorbidities with pancreatic cancer risk.Unprocessed red meat and processed meat consumption and risk of stroke in the Spanish cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC).Sweet-beverage consumption and risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC).Dietary polyphenol intake in Europe: the European Prospective Investigation into Cancer and Nutrition (EPIC) study.No association between fish consumption and risk of stroke in the Spanish cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Spain): a 13·8-year follow-up study.
P50
Q28601163-9C839FDA-C128-45A1-B772-0166D8F9F7CEQ28655880-F15FADCE-FC82-436D-82BD-93D663D8B111Q28658727-69BB4F8F-8C8D-4CC8-A49F-5FFB6AD58738Q34036279-54824D79-2CE3-4889-865A-1B8C77E57668Q34036508-B18375D4-1D53-405A-9574-16E20F498DEFQ34113479-8A86B9A0-87B6-46F5-83C8-5A8A2F0413FCQ34522356-2461E20E-8751-4CE8-93BB-256102408D83Q34578758-4BB61CE8-A3F9-4D1A-9FEA-6A2C98EBB076Q34614320-2FB5D8C4-883C-4B5D-B7B2-E9BAFC536F5FQ34674345-0FFF5B82-B9C0-4AD4-8A5E-53CC095B1303Q34882075-CCC00832-C0FF-4F4D-9FEF-EC4C387CE2DFQ34950883-5EA6860A-EBA0-408A-B72B-3CC47AC50871Q35062955-6CC8327A-9C99-427C-9C93-7F0DD4BDDB1CQ35179825-09136388-7DA7-4E49-8002-563A4B5D02B4Q35678042-385127AD-3C4E-48EF-A0BC-69F4DE18FD7DQ35785514-61F9565B-DFBE-43D1-BA8D-482EB3ED8F1BQ35826696-8507C98C-59D8-48B0-A597-4A9EFA73D0C4Q35835118-7EE14298-B85E-4E8A-8B1E-C4EEC6931B6DQ36013544-882CDB0B-F58F-41C7-A216-2FA099BBDDD3Q36406285-71CDE514-6476-4584-9800-0BB99BB48894Q36616633-62888467-8F2A-40DD-9AB8-A7298FA8361FQ37105257-8981F4CC-7831-426C-B0E5-71902F0133BDQ37273861-526C91B4-0E2B-48E6-873A-8D72C4DD3978Q37331353-B94E2A3B-3ADA-43DD-BFEC-0752F76F58F3Q37460846-7C71F083-F05E-4783-987A-034F8F204112Q37590374-1C654948-048A-4CAD-BAB2-163620333B36Q38166318-59AB4908-5167-43E1-B828-1F11D4563013Q38275366-5A0FC3E7-9437-4ADF-9D90-B2F25F710091Q38281709-2C4802C6-8E9B-40F0-83F7-DF4B85E61CF4Q38426490-047C30B5-474A-4F47-9679-67A8A2E09D7BQ38660884-0CEE1BA5-E694-422C-9268-7381693E2F12Q39597022-032A260E-0E2D-4643-B3B9-0DECB690291AQ39881854-37144D16-09BB-4C88-8BAD-8359B94F94DEQ39932552-1395E915-A0E6-4CED-B14C-51AE470D9ACAQ40009373-DA6461F4-6A8D-494D-8F5B-46F1957FA532Q40255128-07DEA9DC-E6B1-4B3D-A41D-E4E7FDF6D5C1Q40486247-5FF1583A-129F-401A-A62E-FA6650DD5E29Q40627556-174E3D00-7382-4419-B7E7-914E4A823CF8Q40829403-B9F8DCF1-9D58-4A10-836A-EAD33B698DEBQ40908298-D2B6A11D-860E-4EC8-AADA-A4BF9A34669B
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Esther Molina-Montes
@ast
Esther Molina-Montes
@en
Esther Molina-Montes
@es
Esther Molina-Montes
@nl
Esther Molina-Montes
@sl
type
label
Esther Molina-Montes
@ast
Esther Molina-Montes
@en
Esther Molina-Montes
@es
Esther Molina-Montes
@nl
Esther Molina-Montes
@sl
altLabel
E Molina-Montes
@en
Molina-Montes E
@en
prefLabel
Esther Molina-Montes
@ast
Esther Molina-Montes
@en
Esther Molina-Montes
@es
Esther Molina-Montes
@nl
Esther Molina-Montes
@sl
P106
P2038
Esther_Molina-Montes
P21
P31
P496
0000-0002-0428-2426